News

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...
This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...
CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...
Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The Trump administration's decision to cut $500 million for new vaccine development raises concerns among health care administrators at UC Davis about potential risks during future outbreaks.
The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...
HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...
The US health department's Biomedical Advanced Research and Development Authority is "terminating 22 mRNA vaccine development ...
A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...
The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...